Home
Live
News
Create
Screeners
Insights
Albert David
792.
00
-2.00
(-0.25%)
Market Cap
₹453.10 Cr
PE Ratio
71.54
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.25%
1M
-1.31%
6M
-7.01%
1Y
-41.58%
5Y
+96.45%
View Company Insights
Latest news about Albert David
Albert David Shareholders Approve Dr. Rajiv Anant Desai's Appointment as Independent Director
Sep 17, 2025
Albert David, a pharmaceutical company, has appointed Dr. Rajiv Anant Desai as an Independent Director for a five-year term from August 2, 2025, to August 1, 2030. The appointment was approved through a postal ballot with 99.99% of votes in favor. Dr. Desai, with over 38 years of experience in the pharmaceutical industry, holds a Ph.D. in Pharmaceutical Chemistry and an MBA. He previously served as Executive Vice President at Lupin Limited and currently works as a Senior Technical Advisor with the Indian Pharmaceutical Alliance.
Albert David Limited Reports Mixed Q1 FY2026 Results with Decline in Revenue and Profit
Aug 04, 2025
Albert David Limited Appoints Pharma Veteran as New Independent Director, Approves Q1 Results
Aug 02, 2025
Albert David Reports 59% Decline in Q1 Net Profit, Appoints New Independent Director
Aug 02, 2025
Albert David Ltd Reports Q4 FY23 Results: EBITDA Loss Widens, Revenue Declines; Recommends Dividend
May 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation